Response to the comment "Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?"

Pharmacol Res. 2021 Dec:174:105876. doi: 10.1016/j.phrs.2021.105876. Epub 2021 Nov 16.

¹ Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Naples, Italy; Department of Experimental Medicine - Section of Pharmacology "L. Donatelli", University of Campania "Luigi Vanvitelli", Naples, Italy.
² Department of Medical and Surgical Advanced Science, University of Campania "Luigi Vanvitelli", Naples, Italy.
³ Medical Statistics Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.
⁴ Department of Medical and Surgical Advanced Science, University of Campania "Luigi Vanvitelli", Naples, Italy; Mediterranea Cardiocentro, Naples, Italy.

No abstract available

Publication types